Akebia Therapeutics (AKBA) EBIT Margin (2017 - 2026)
Akebia Therapeutics' EBIT Margin came in at -12.88% for Q2 2026, down 35.43 percentage points from 22.55% a year earlier and down 4.11 percentage points from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) EBIT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Akebia Therapeutics reported EBIT Margin of -6.90%, down 7.29 percentage points year-over-year; for FY2025, it came in at 9.95%, up 41.46 percentage points from FY2024.
- EBIT Margin carries a five-year change of +138.18 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -31.51% in FY2024 (-7.74 pp), -23.77% in FY2023 (+3.85 pp), -27.62% in FY2022 (+97.35 pp) and -124.97% in FY2021 (+3.26 pp).
- The five-year range for quarterly EBIT Margin is -113.28% (Q4 2021) to 26.97% (Q2 2022).
- Year-over-year, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +8.18 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2022 (a gain of 176.91 percentage points), and the weakest in Q2 2023 (a drop of 42.92 percentage points).
- Business Quant data shows AKBA's EBIT Margin at -8.77% (Q1 2026), -14.84% (Q4 2025) and 7.57% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | -12.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.88% |
| Mar 31, 2026 | -8.77% |
| Dec 31, 2025 | -14.84% |
| Sep 30, 2025 | 7.57% |
| Jun 30, 2025 | 22.55% |
| Mar 31, 2025 | 23.57% |
| Dec 31, 2024 | -30.77% |
| Sep 30, 2024 | -33.41% |
| Jun 30, 2024 | -19.99% |
| Mar 31, 2024 | -45.81% |
| Dec 31, 2023 | 2.45% |
| Sep 30, 2023 | -31.00% |
| Jun 30, 2023 | -15.96% |
| Mar 31, 2023 | -63.98% |
| Dec 31, 2022 | -8.73% |
| Sep 30, 2022 | -103.47% |
| Jun 30, 2022 | 26.97% |
| Mar 31, 2022 | -96.57% |
| Dec 31, 2021 | -113.28% |
| Sep 30, 2021 | -112.57% |
API Access
Akebia Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();